Moscow, Mar 19: The Russian military says it used its latest hypersonic missile, Kinzhal, for the first time in combat during its offensive in Ukraine.
Spokesman for the Russian Defense Ministry Maj. Gen. Igor Konashenkov said the hypersonic missiles destroyed an underground warehouse storing missiles and aviation ammunition of Ukrainian troops in the western Ivano-Frankivsk region.
Konashenkov also said that the Russian forces used the anti-ship missile system Bastion to strike Ukrainian military facilities near the Black Sea port of Odesa.
Russia first used the weapon during its military campaign in Syria in 2016.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Bengaluru: In response to the deaths of postnatal women at Ballari District Hospital, the Karnataka government has temporarily suspended the use of IV Ringer Lactate solution across the state as a precautionary measure, Health Minister Dinesh Gundu Rao announced on Saturday.
Speaking to the media in Bengaluru, the minister explained that doubts about the quality of the IV solution had arisen, prompting the decision. He clarified that Ringer Lactate, along with glucose solutions, has been routinely used in hospitals for years. However, out of the 192 batches supplied by the Karnataka State Drugs Logistics and Warehousing Society, concerns were raised regarding two specific batches.
"In light of these concerns, we stopped the use of all 192 batches as a precaution. Following this, the supplying company obtained a High Court order for testing, and the Central Drugs Laboratory (CDL) conducted an analysis. The CDL report confirmed the usability of the solution, allowing the state to form a technical committee to review and permit the use of certain batches that met quality standards. Despite this, doubts have surfaced specifically at Ballari District Hospital," the minister stated.
To address these concerns, the batches supplied to Ballari Hospital have been sent for anaerobic testing to determine whether the IV solution contributed to the deaths. The test results are expected within a week, after which a final decision on the use of IV Ringer Lactate will be made.
"Until then, we have issued directives to hospitals statewide to suspend the use of IV Ringer Lactate. Every life is important to us, and precautionary measures are essential when suspicions arise," Gundu Rao emphasised.